Very late relapse of high-grade osteosarcoma: A case report and review of the literature.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
17 Jul 2020
Historique:
entrez: 25 7 2020
pubmed: 25 7 2020
medline: 4 8 2020
Statut: ppublish

Résumé

Osteosarcoma is the most common primary malignant bone tumor in children. The prognosis of osteosarcoma has improved with the use of aggressive systemic chemotherapy in addition to surgery. The relapse of osteosarcomas is usually as lung metastasis observed within 2 to 3 years after the initial treatment. A relapse is rarely observed at >10 years. We report the case of a 51-year-old Japanese man who was treated for high-grade osteosarcoma of the femur at 13 years old. He was referred to our hospital with a suspicion of primary lung cancer based on back pain, respiratory distress, and an abnormal mass on chest radiograph. Computed tomography-guided biopsy confirmed the lung lesion as a metastatic recurrence of high-grade osteosarcoma without local recurrence. Chemotherapy was planned, but the patient's general condition rapidly deteriorated and thus palliative therapy was provided. The patient died 2 months after the initial consultation. The survival durations of osteosarcoma patients have been prolonged by recent progress in multimodality therapy, and thus clinicians as well as osteosarcoma patients should always keep in mind the possibility of very late relapse.

Identifiants

pubmed: 32702886
doi: 10.1097/MD.0000000000021206
pii: 00005792-202007170-00081
pmc: PMC7373632
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e21206

Références

Cancer. 1993 Jan 15;71(2):338-45
pubmed: 8422626
Ann R Coll Surg Engl. 2009 May;91(4):W17-9
pubmed: 19416582
J Clin Oncol. 2002 Feb 1;20(3):776-90
pubmed: 11821461
Intern Med J. 2007 Jun;37(6):420-2
pubmed: 17535392
Eur J Cancer. 2003 Sep;39(14):2050-7
pubmed: 12957460
Clin Orthop Relat Res. 1996 Jan;(322):198-206
pubmed: 8542697
Gen Thorac Cardiovasc Surg. 2008 Dec;56(12):613-5
pubmed: 19085058
J Orthop Sci. 2017 Mar;22(2):357-361
pubmed: 26755392
Oncol Lett. 2013 Jul;6(1):23-27
pubmed: 23946772
Ann Oncol. 2012 Jun;23(6):1607-16
pubmed: 22015453
Eur J Cancer. 2006 Mar;42(4):460-6
pubmed: 16426841
Ann Oncol. 1998 Aug;9(8):893-9
pubmed: 9789613
Sarcoma. 2012;2012:764796
pubmed: 22851905
J Pediatr Hematol Oncol. 2006 Jul;28(7):418-22
pubmed: 16825986
J Med Case Rep. 2009 Nov 24;3:9298
pubmed: 20062787
Pediatr Blood Cancer. 2004 Nov;43(6):692-7
pubmed: 15390283
Hum Pathol. 2006 Aug;37(8):1009-14
pubmed: 16867863
J Clin Oncol. 2005 Jan 20;23(3):559-68
pubmed: 15659502
Clin Orthop Relat Res. 2008 Jun;466(6):1318-22
pubmed: 18425560
J Clin Oncol. 1992 Jan;10(1):5-15
pubmed: 1370176

Auteurs

Yoichi Kaneuchi (Y)

Department of Orthopaedic Surgery.

Michiyuki Hakozaki (M)

Department of Orthopaedic Surgery.

Hitoshi Yamada (H)

Department of Orthopaedic Surgery.

Osamu Hasegawa (O)

Department of Radiology.

Shoki Yamada (S)

Department of Pathology and Diagnostic Pathology, Fukushima Medical University School of Medicine.

Yuka Oka (Y)

Department of Pathology and Diagnostic Pathology, Fukushima Medical University School of Medicine.

Kazuo Watanabe (K)

Fukushima Pathology Laboratory, Fukushima, Japan.

Shinichi Konno (S)

Department of Orthopaedic Surgery.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH